Association of SET domain and myotubularin-related proteins modulates growth control

Nature Genetics
X CuiM L Cleary

Abstract

Several proteins that contribute to epigenetic mechanisms of gene regulation contain a characteristic motif of unknown function called the SET (Suvar3-9, Enhancer-of-zeste, Trithorax) domain. We have demonstrated that SET domains mediate highly conserved interactions with a specific family of proteins that display similarity with dual-specificity phosphatases (dsPTPases). These include myotubularin, the gene of which is mutated in a subset of patients with X-linked myotubular myopathy, and Sbf1, a newly isolated homologue of myotubularin. In contrast with myotubularin, Sbf1 lacks a functional catalytic domain which dephosphorylates phospho-tyrosine and serine-containing peptides in vitro. Competitive interference of endogenous SET domain-dsPTPase interactions by forced expression of Sbf1 induced oncogenic transformation of NIH 3T3 fibroblasts and impaired the in vitro differentiation of C2 myoblast cells. We conclude that myotubularin-type phosphatases link SET-domain containing components of the epigenetic regulatory machinery with signalling pathways involved in growth and differentiation.

References

Dec 1, 1990·Trends in Genetics : TIG·R Paro
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M StreuliH Saito
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J A Kennison, J W Tamkun
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R BaskaranJ Y Wang
Nov 10, 1995·The Journal of Biological Chemistry·M J WishartJ E Dixon
Sep 15, 1995·Science·K GalaktionovD Beach
Mar 11, 1994·Science·D BarfordN K Tonks
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·J M DenuJ E Dixon
May 31, 1996·Science·J YuvaniyamaM A Saper
Apr 1, 1996·Current Opinion in Cell Biology·M Streuli
Nov 1, 1996·Cell·J M DenuJ E Dixon
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·A J FlintN K Tonks
Apr 1, 1997·Current Opinion in Genetics & Development·V Pirrotta

❮ Previous
Next ❯

Citations

Jul 18, 2001·Annals of Neurology·J LaporteJ L Mandel
Mar 29, 2000·Biochemical and Biophysical Research Communications·R ZhaoZ J Zhao
Sep 21, 2001·Biochemical and Biophysical Research Communications·E LevivierI Callebaut
Nov 15, 2005·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Gareth R HowellJohn C Schimenti
Mar 20, 2002·Current Neurology and Neuroscience Reports·Cornelius F BoerkoelJames R Lupski
May 21, 2005·Biochemical and Biophysical Research Communications·Kazunori ShibuyaNobuyoshi Shimizu
Mar 29, 2001·Trends in Genetics : TIG·J LaporteJ L Mandel
Jan 10, 2002·Biochimica Et Biophysica Acta·I Muyrers-Chen, R Paro
Jun 1, 2002·Gene·Raul Alvarez-Venegas, Zoya Avramova
Sep 18, 2003·Brain & Development·Asuri N Prasad, Chitra Prasad
Mar 15, 2001·Current Opinion in Cell Biology·M J WishartJ E Dixon
Sep 21, 2000·Neuromuscular Disorders : NMD·C Wallgren-Pettersson
Nov 26, 1998·Neuromuscular Disorders : NMD·C Wallgren-Pettersson
May 18, 2001·Trends in Cell Biology·T Jenuwein
Aug 2, 2002·Trends in Biochemical Sciences·Robert SchneiderTony Kouzarides
Oct 3, 1998·Trends in Biochemical Sciences·M J Wishart, J E Dixon
Aug 31, 1999·Clinical Genetics·B G HäneC E Schwartz
Oct 9, 2002·Immunological Reviews·Andris AvotsAlbrecht M Müller
Jan 20, 2004·Nature Cell Biology·Sheryl T SmithAlexander Mazo
Apr 16, 1998·Nature Genetics·T Hunter
Aug 22, 2002·Nature Reviews. Cancer·Shi Huang
Apr 4, 2001·The Biochemical Journal·D J GilloolyH Stenmark
Sep 1, 1999·British Journal of Haematology·J F Dimartino, M L Cleary
Dec 11, 2002·The Plant Journal : for Cell and Molecular Biology·Yannick BellecJean-Denis Faure
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·P Joy HoDouglas Joshua
Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Jun 4, 2002·Current Opinion in Hematology·Patricia ErnstStanley J Korsmeyer
Jun 4, 2002·Current Opinion in Hematology·Ari Melnick, Jonathan D Licht
Sep 7, 2001·Genes & Development·K R KatsaniC P Verrijzer
Jun 8, 2001·Molecular and Cellular Biology·D O'CarrollT Jenuwein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.